Literature DB >> 13520829

The lymphocyst: a complication of pelvic lymph node dissections.

M J GRAY, A A PLENTL, H C TAYLOR.   

Abstract

Keywords:  CERVIX NEOPLASMS/surgery; LYMPH NODES/surgery; LYMPHOMA; RETROPERITONEAL SPACE/neoplasms

Mesh：

Year:  1958        PMID： 13520829     DOI： 10.1016/0002-9378(58)90825-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  8 in total

1.  PELVIC LYMPHOCYST.

Authors:  L J QUINN; P DORR
Journal:  Can Med Assoc J       Date:  1964-05-30       Impact factor: 8.262

2.  [Gynecological aspects of retroperitoneal diseases (author's transl)].

Authors:  V Jalůvka
Journal:  Arch Gynakol       Date:  1976-03-05

3.  Pseudorejection: factors mimicking rejection in renal allograft recipients.

Authors:  A J Matas; R L Simmons; C M Kjellstrand; J S Najarian
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

Review 4.  Lymphocele.

Authors:  K S Metcalf; K R Peel
Journal:  Ann R Coll Surg Engl       Date:  1993-11       Impact factor: 1.891

5.  Internal drainage of lymphocele by a pedicled omental flap.

Authors:  S Ali Khan; K N Hu
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

6.  What Are the Risk Factors for Lymphocyst Formation Apart From Lymphnode Dissection and Lymphnode Count in Gynecologic Malignancy?

Authors:  A Sahbaz; K Gungorduk; V Gulseren; I A Ozdemir; M Harma; M Harma; M Sancı
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-04       Impact factor: 2.915

7.  Effective management of pelvic lymphocysts by laparoscopic marsupialization.

Authors:  F O Recio; S Ghamande; R E Hempling; M S Piver
Journal:  JSLS       Date:  1999 Apr-Jun       Impact factor: 2.172

8.  Predictors of Lymphoceles in Women Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecologic Cancer: A Retrospective Cohort Study.

Authors:  Hui-Hua Chen; Wan-Hua Ting; Ho-Hsiung Lin; Sheng-Mou Hsiao
Journal:  Int J Environ Res Public Health       Date:  2019-03-15       Impact factor: 3.390
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.